- Home
- HTCR vs ANTX Comparison
HTCR vs ANTX Comparison
Compare HTCR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCR
- ANTX
- Stock Information
- Founded
- HTCR 2009
- ANTX 2017
- Country
- HTCR Japan
- ANTX United States
- Employees
- HTCR N/A
- ANTX N/A
- Industry
- HTCR EDP Services
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- HTCR Technology
- ANTX Health Care
- Exchange
- HTCR Nasdaq
- ANTX Nasdaq
- Market Cap
- HTCR 36.2M
- ANTX 40.0M
- IPO Year
- HTCR 2022
- ANTX 2022
- Fundamental
- Price
- HTCR $1.39
- ANTX $1.34
- Analyst Decision
- HTCR
- ANTX Hold
- Analyst Count
- HTCR 0
- ANTX 5
- Target Price
- HTCR N/A
- ANTX $3.50
- AVG Volume (30 Days)
- HTCR 223.1K
- ANTX 933.0K
- Earning Date
- HTCR 11-14-2024
- ANTX 11-13-2024
- Dividend Yield
- HTCR 5.18%
- ANTX N/A
- EPS Growth
- HTCR N/A
- ANTX N/A
- EPS
- HTCR 0.23
- ANTX N/A
- Revenue
- HTCR $30,290,930.00
- ANTX N/A
- Revenue This Year
- HTCR $65.36
- ANTX N/A
- Revenue Next Year
- HTCR N/A
- ANTX N/A
- P/E Ratio
- HTCR $6.58
- ANTX N/A
- Revenue Growth
- HTCR 47.63
- ANTX N/A
- 52 Week Low
- HTCR $0.45
- ANTX $0.87
- 52 Week High
- HTCR $1.89
- ANTX $22.22
- Technical
- Relative Strength Index (RSI)
- HTCR 48.50
- ANTX 50.02
- Support Level
- HTCR $1.47
- ANTX $1.32
- Resistance Level
- HTCR $1.75
- ANTX $1.59
- Average True Range (ATR)
- HTCR 0.16
- ANTX 0.09
- MACD
- HTCR -0.03
- ANTX -0.03
- Stochastic Oscillator
- HTCR 2.08
- ANTX 7.89
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.